drugset / Trial / NCT01544309

LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts

NCT01544309

Completed 1049 enrolled Listen Trial Group
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of rosuvastatin and atorvastatin on lipid lowering effect and glucose metabolism in hypercholesterolemia patients with diabetes mellitus.

Timeline

Start
2012-03
Primary completion
2014-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral
Subject Atorvastatin Small molecule 20 mg Oral
Subject Rosuvastatin Small molecule 5 mg Oral
Subject Rosuvastatin Small molecule 10 mg Oral

Indications